Microbot Medical Inc
F:CY9D
Microbot Medical Inc
F:CY9D
Price:
2.388
EUR
3.83%
Market Cap:
€38.1m
Relative Value
The Relative Value of one
CY9D
stock under the Base Case scenario is
0.181
EUR.
Compared to the current market price of 2.388 EUR,
Microbot Medical Inc
is
Overvalued by 92%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CY9D
Relative Value
Base Case
0.181
EUR
Overvaluation 92%
Multiples Across Competitors
CY9D Competitors Multiples
Microbot Medical Inc Competitors
Microbot Medical Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Microbot Medical Inc
F:CY9D
|
179.7m EUR | 0 | -13.8 | -7.3 | -7.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
187.8B USD | 4.2 | 28.7 | 16.5 | 22.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
169.9B USD | 16.4 | 57.7 | 43.7 | 53.8 | |
| US |
|
Stryker Corp
NYSE:SYK
|
129.9B USD | 5.1 | 39.8 | 20.3 | 24.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.1B USD | 3.2 | 24.4 | 13.4 | 19.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
102B USD | 5.1 | 35.2 | 20.7 | 27.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.9B EUR | 1.9 | 20.8 | 11.6 | 16.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.1B USD | 7.9 | 44.6 | 24.5 | 26.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.5B USD | 10.5 | 42.8 | 30.5 | 33.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.5B USD | 2.1 | 26.1 | 10.2 | 17.3 | |
| US |
|
Resmed Inc
NYSE:RMD
|
34.1B USD | 6.3 | 22.8 | 16.1 | 17.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
